Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate

Grants

Funding Acknowledgements

This work was conducted as part of the Hilton-Ludwig Cancer Metastasis Initiative, funded by the Conrad N. Hilton Foundation and the Ludwig Insitute for Cancer Research.The following Austin Health medical oncology fellows contributed patient tumours to this study: Mark Shackleton, Phillip Parente, Catherine Barrow and Oliver Klein. We also thank Sunanta Lee and Belinda Rutledge who created and maintain the melanoma database. I.D.D. is supported in part by a Victorian Cancer Agency Clinical Researcher Fellowship and is an Australian National Health and Medical Research Council (NHMRC) Honorary Practitioner Fellow. J.C. is an NHMRC Practitioner Fellow. R.A.S. and R.M. are supported by the Cancer Institute New South Wales Clinical Research Fellowship program. Assistance of the staff of the Melanoma Institute Australia/Sydney Melanoma Unit is also gratefully acknowledged.